Rapport Therapeutics Inc. Common Stock (RAPP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rapport Therapeutics Inc....

    NASDAQ: RAPP · Real-Time Price · USD
    28.54
    0.00 (0.00%)
    At close: Oct 03, 2025, 3:59 PM
    28.54
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Rapport Therapeutics Common Stock Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Net Income
    		 -78.31M -34.79M -10.65M
    Depreciation & Amortization
    		 839K 112K 16.36K
    Stock-Based Compensation
    		 10.23M 3.52M 609.82K
    Other Working Capital
    		 -2.07M 1.8M 1.49M
    Other Non-Cash Items
    		 4.82M 1.32M 5.3M
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 -2.42M 2.65M 1.49M
    Operating Cash Flow
    		 -64.83M -27.18M -3.24M
    Capital Expenditures
    		 -2.4M -1.64M -284K
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 -380.74M -77.22M n/a
    Sales Maturities Of Investments
    		 209.8M n/a n/a
    Other Investing Acitivies
    		 3.21M n/a -5M
    Investing Cash Flow
    		 -170.14M -78.86M -5.28M
    Debt Repayment
    		 n/a n/a 7.9M
    Common Stock Repurchased
    		 n/a -4K n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 7K -134K n/a
    Financial Cash Flow
    		 221.63M 145.14M 39.69M
    Net Cash Flow
    		 -13.34M 39.09M 31.16M
    Free Cash Flow
    		 -67.23M -28.82M -3.53M

    Add to Watchlist